Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: CMC PHARMACEUTICALS, INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-09-22 to 2024-10-18
Current total value of award: $1099975.08
Description: SBIR PHASE II - OPTION YEAR